Cargando…
Utility of p63 and p40 in Distinguishing Polymorphous Adenocarcinoma and Adenoid Cystic Carcinoma
OBJECTIVE: Adenoid cystic carcinoma and polymorphous adenocarcinoma are primarily the tumor of minor salivary glands. Both show certain morphological similarities, which limit their proper diagnosis in settings where there are obscuring factors and limited biopsy material. However, there is a consid...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982655/ https://www.ncbi.nlm.nih.gov/pubmed/31653135 http://dx.doi.org/10.31557/APJCP.2019.20.10.2917 |
_version_ | 1783491338281418752 |
---|---|
author | Atiq, Aribah Mushtaq, Sajid Hassan, Usman Loya, Asif Hussain, Mudassir Akhter, Noreen |
author_facet | Atiq, Aribah Mushtaq, Sajid Hassan, Usman Loya, Asif Hussain, Mudassir Akhter, Noreen |
author_sort | Atiq, Aribah |
collection | PubMed |
description | OBJECTIVE: Adenoid cystic carcinoma and polymorphous adenocarcinoma are primarily the tumor of minor salivary glands. Both show certain morphological similarities, which limit their proper diagnosis in settings where there are obscuring factors and limited biopsy material. However, there is a considerable difference in treatment and prognosis, which raises the need to distinguish these two entities. In this study, we discuss the utility of two immunohistochemical stains, p63 and p40, in different combinations for distinguishing polymorphous adenocarcinoma from adenoid cystic carcinoma. MATERIALS AND METHODS: Two immunohistochemical stains, p63 and p40, were performed on 47 cases of adenoid cystic carcinoma and 23 cases of polymorphous adenocarcinoma. RESULTS: 36 out of 47 cases of adenoid cystic carcinoma showed p63+ve/p40+ve immunoprofile, followed by p63-ve/p40-ve immunoprofile, which is seen in10 cases of adenoid cystic carcinoma. However, 22 out of 23 cases of polymorphous adenocarcinoma displayed p63+ve/p40-ve immunoprofile. p63-ve/p40+ve is the least frequent observed immunoprofile, which is seen in only one case of adenoid cystic carcinoma. CONCLUSION: On combining all possible immunoprofile combinations, p63+ve/p40-ve immunoprofile appears to be the most sensitive profile for distinguishing polymorphous adenocarcinoma from adenoid cystic carcinoma. |
format | Online Article Text |
id | pubmed-6982655 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | West Asia Organization for Cancer Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-69826552020-07-07 Utility of p63 and p40 in Distinguishing Polymorphous Adenocarcinoma and Adenoid Cystic Carcinoma Atiq, Aribah Mushtaq, Sajid Hassan, Usman Loya, Asif Hussain, Mudassir Akhter, Noreen Asian Pac J Cancer Prev Research Article OBJECTIVE: Adenoid cystic carcinoma and polymorphous adenocarcinoma are primarily the tumor of minor salivary glands. Both show certain morphological similarities, which limit their proper diagnosis in settings where there are obscuring factors and limited biopsy material. However, there is a considerable difference in treatment and prognosis, which raises the need to distinguish these two entities. In this study, we discuss the utility of two immunohistochemical stains, p63 and p40, in different combinations for distinguishing polymorphous adenocarcinoma from adenoid cystic carcinoma. MATERIALS AND METHODS: Two immunohistochemical stains, p63 and p40, were performed on 47 cases of adenoid cystic carcinoma and 23 cases of polymorphous adenocarcinoma. RESULTS: 36 out of 47 cases of adenoid cystic carcinoma showed p63+ve/p40+ve immunoprofile, followed by p63-ve/p40-ve immunoprofile, which is seen in10 cases of adenoid cystic carcinoma. However, 22 out of 23 cases of polymorphous adenocarcinoma displayed p63+ve/p40-ve immunoprofile. p63-ve/p40+ve is the least frequent observed immunoprofile, which is seen in only one case of adenoid cystic carcinoma. CONCLUSION: On combining all possible immunoprofile combinations, p63+ve/p40-ve immunoprofile appears to be the most sensitive profile for distinguishing polymorphous adenocarcinoma from adenoid cystic carcinoma. West Asia Organization for Cancer Prevention 2019 /pmc/articles/PMC6982655/ /pubmed/31653135 http://dx.doi.org/10.31557/APJCP.2019.20.10.2917 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Atiq, Aribah Mushtaq, Sajid Hassan, Usman Loya, Asif Hussain, Mudassir Akhter, Noreen Utility of p63 and p40 in Distinguishing Polymorphous Adenocarcinoma and Adenoid Cystic Carcinoma |
title | Utility of p63 and p40 in Distinguishing Polymorphous Adenocarcinoma and Adenoid Cystic Carcinoma |
title_full | Utility of p63 and p40 in Distinguishing Polymorphous Adenocarcinoma and Adenoid Cystic Carcinoma |
title_fullStr | Utility of p63 and p40 in Distinguishing Polymorphous Adenocarcinoma and Adenoid Cystic Carcinoma |
title_full_unstemmed | Utility of p63 and p40 in Distinguishing Polymorphous Adenocarcinoma and Adenoid Cystic Carcinoma |
title_short | Utility of p63 and p40 in Distinguishing Polymorphous Adenocarcinoma and Adenoid Cystic Carcinoma |
title_sort | utility of p63 and p40 in distinguishing polymorphous adenocarcinoma and adenoid cystic carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982655/ https://www.ncbi.nlm.nih.gov/pubmed/31653135 http://dx.doi.org/10.31557/APJCP.2019.20.10.2917 |
work_keys_str_mv | AT atiqaribah utilityofp63andp40indistinguishingpolymorphousadenocarcinomaandadenoidcysticcarcinoma AT mushtaqsajid utilityofp63andp40indistinguishingpolymorphousadenocarcinomaandadenoidcysticcarcinoma AT hassanusman utilityofp63andp40indistinguishingpolymorphousadenocarcinomaandadenoidcysticcarcinoma AT loyaasif utilityofp63andp40indistinguishingpolymorphousadenocarcinomaandadenoidcysticcarcinoma AT hussainmudassir utilityofp63andp40indistinguishingpolymorphousadenocarcinomaandadenoidcysticcarcinoma AT akhternoreen utilityofp63andp40indistinguishingpolymorphousadenocarcinomaandadenoidcysticcarcinoma |